Stay up to date with the latest research, tips, and trends in fitness, nutrition, and weight management.
Australians are turning to high-THC cannabis for anxiety, PTSD and depression, but the evidence is limited, mixed, and raises safety concerns.
Bumble, Tinder or Hinge—they're the fast-paced, image-driven dating platforms millions rely on to find everything from love to a late-night fling. But new Adelaide University research suggests they may also be undermining how young adults see their bodies.
Metformin raised the exercise-linked metabolite Lac-Phe in prostate cancer patients across disease stages and treatment settings, while Lac-Phe itself did not predict anticancer response. Patients in the BIMET-1 metformin arm also showed better weight management during anti-androgen therapy, highlighting a possible metabolic benefit relevant to prostate cancer care.
An international team of researchers, led in part by scientists at the University of Florida and Trinity College Dublin, has solved a long-standing
Researchers combined 11 international resting-state fMRI datasets to map how psychedelic drugs reshape brain connectivity across cortical and subcortical circuits. The mega-analysis found a shared signature of stronger coupling between transmodal association networks and unimodal or sensorimotor systems, alongside selective and variable reductions in within-network connectivity.
A growing body of research shows that diabetes can be stratified into five different subgroups. Researchers at Lund University have now investigated whether a person's genetic predisposition to different diabetes subgroups can help assess the risk of developing coronary artery disease. The team created genetic risk scores and found that the scores for one subgroup could predict coronary artery disease, even before the onset of diabetes.
PESHAWAR: Khyber Pakhtunkhwa has moved closer to interrupting poliovirus transmission as no confirmed case of the crippling disease has been reported in the province in 2026 so far.The environment...
Researchers have identified a previously unknown neurodevelopmental disorder influenced by genetics – a discovery that promises new diagnoses for thousands of children and families worldwide.
Scientists at Cornell University may be closing in on the long-sought “holy grail” of male contraception: a safe, reversible, nonhormonal method that completely halts sperm production. In a breakthrough mouse study, researchers used a compound called JQ1 to temporarily shut down meiosis—the critical process that produces sperm—without causing lasting harm. After treatment stopped, sperm production bounced back, fertility returned, and the animals produced healthy offspring.
And it may be relatively prevalent.